Pfizer Hemophilia drug Hympavzi Receives USFDA Approval MD Bureau14 Oct 2024 2:08 PM ISTPfizer announced on Friday that the U.S. Food and Drug Administration has granted approval for its once-weekly injection designed to treat the two...
Indian Drug Regulator Meets WHO Standards for Functional Vaccine Regulatory System MD Bureau14 Oct 2024 2:04 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) and the National Regulatory Authority of India have successfully met the World...
Received CDSCO nod for Nafithromycin Antibiotic for CABP, says Wockhardt MD Bureau14 Oct 2024 1:21 PM ISTNew Delhi: Pharmaceutical company Wockhardt has announced that it has received a positive recommendation from the national drug regulator for its...
Manufacturing Defects: Glenmark Subsidiary Recalls Products in US Meghna A Singhania14 Oct 2024 1:14 PM ISTNew York: Glenmark Pharmaceuticals is recalling two products in the U.S. due to manufacturing problems, as reported by the U.S. Food and Drug...
Serum Institute of India gets CDSCO Panel nod to study Measles, Mumps, and Rubella Vaccine Live Freeze-Dried Dr. Divya Colin13 Oct 2024 6:00 PM ISTNew Delhi: Vaccine major Serum Institute of India has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal for Tozorakimab Study Dr. Divya Colin13 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved AstraZeneca's...
J&J talc bankruptcy stays in Texas despite 'forum-shopping' opposition MD Bureau Team13 Oct 2024 12:48 PM ISTNew York: A Johnson & Johnson subsidiary can pursue its third attempt to resolve tens of thousands of lawsuits alleging its talc...
MSD Phase 3 trial of head and neck cancer treatment meets primary endpoint Ruchika Sharma13 Oct 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA...
Biotechnology to Drive India's Next Industrial Revolution: Dr. Jitendra Singh MD Bureau12 Oct 2024 2:37 PM ISTNew Delhi: Union Minister of State for Science and Technology, Jitendra Singh, highlighted India's expanding role as a global leader in...
Fortis Healthcare to Raise Rs 1,500 Crore Through NCDs MD Bureau12 Oct 2024 2:30 PM ISTNew Delhi: Fortis Healthcare Ltd recently announced that its board has approved raising up to Rs 1,500 crore through the issuance of...
Zydus receives USFDA nod for Paliperidone ER Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg MD Bureau Team12 Oct 2024 12:00 PM ISTAhmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as "Zydus") has received final approval from the...
Alkem Labs inks pact with Sonnet BioTherapeutics to develop, commercialise drug candidate for diabetic peripheral neuropathy in India Ruchika Sharma12 Oct 2024 11:00 AM ISTMumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to develop, manufacture and...
